A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
Condition(s):Non-Small Cell Lung CancerLast Updated:October 20, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Non-Small Cell Lung CancerLast Updated:October 20, 2011Completed
Condition(s):Prostate CancerLast Updated:June 24, 2013Completed
Condition(s):NSCLCLast Updated:October 20, 2011Completed
Condition(s):Colorectal Cancer; Small Intestine CancerLast Updated:July 24, 2013Withdrawn
Condition(s):Breast Neoplasms; Metastases, NeoplasmLast Updated:October 24, 2012Completed
Condition(s):Prostate CancerLast Updated:July 1, 2016Completed
Condition(s):Lung CancerLast Updated:June 15, 2023Completed
Condition(s):Lung CancerLast Updated:December 7, 2016Completed
Condition(s):Prostate CancerLast Updated:August 7, 2018Completed
Condition(s):GlaucomaLast Updated:November 21, 2014Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.